Support info of Effects of hyperfractionated radiotherapy versus hypofractionated radiotherapy combined with concurrent chemotherapy on prognosis of limited-stage small-cell lung cancer

中华放射肿瘤学杂志


	2017, Vol. 26(9): 1000-1005 DOI: 10.3760/cma.j.issn.1004-4221.2017.09.005

	Effects of hyperfractionated radiotherapy versus hypofractionated radiotherapy combined with concurrent chemotherapy on prognosis of limited-stage small-cell lung cancer
	Hu Xiao,Xia Bing,Bao Yong,Xu Yujin,Wang Jin,Ma Honglian,Jin Ying,Fang Min,Tang Huarong,Chen Mengyuan,Dong Baiqiang,Fu Xiaolong,Chen Ming
	Department of Radiation Oncology,Zhejiang Cancer Hospital,Zhejiang Provincial Key Laboratory of Radiation Oncology,Hangzhou 310022,China (Hu X,Xu YJ,Wang GJ,Ma HL,Fang M,Tang HR,Chen MY,Dong BQ,Chen M);Department of Radiation Oncology,Hangzhou Cancer Hospital,Department of Radiation Oncology,Cancer Hospital of Fudan University (Xia B);Department of Radiation Oncology,Cancer Center of Sun Yat-sen University,Guangzhou 510060,China (Bao Y);Department of Radiation Oncology,Chest Hospital of Shanghai JiaoTong University,Cancer Hospital of Fudan University,Shanghai 200030,China (Fu XL)Hu Xiao and Xia Bing contributed equally to this study
	Received 2017-02-22 Revised null
	Supporting info


	null